EG18268A
(en )
1993-02-28
Medicament for the treatment of inflammation of the eye
IL112029A
(en )
1999-10-28
Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
EP0460912A3
(en )
1992-06-17
Medicaments for the treatment of sexual disorder
GB8900678D0
(en )
1989-03-08
Compositions for the prevention and medical treatment of parodonthopathy
IL129144A0
(en )
2000-02-17
Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
EP0577023A3
(en )
1996-12-18
Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
AU2806692A
(en )
1993-05-03
Medicament for the treatment of anxiety
GB9222260D0
(en )
1992-12-09
Skin treatment
GB9103278D0
(en )
1991-04-03
Drug for the treatment of dermatitis
HU9402816D0
(en )
1994-12-28
Medicament for the treatment of airways inflammation and airways hyperresponsiveness
ZA932450B
(en )
1993-10-20
Drugs for the treatment of diabetes
GB9217124D0
(en )
1992-09-23
Medical treatment
EP0343671A3
(en )
1990-06-13
Pharmaceutical composition for the treatment of skin wounds
ZA947912B
(en )
1995-05-24
Treatment of medical disorders associated with free radical formation
BG98001U
(en )
1995-04-28
Medicament for the treatment of hyperkeratotic conditions of the skin
ZA944671B
(en )
1995-01-16
Medicaments for the treatment of inflammatory diseases
GB9218773D0
(en )
1992-10-21
Skin treatment
GB9216360D0
(en )
1992-09-16
Treatment of blood
ZA931700B
(en )
1993-11-16
Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
ZA936136B
(en )
1994-02-21
Treatment of skin diseases
GB9413939D0
(en )
1994-08-31
Pharmaceutical composition for the treatment of chronic skin ulcers
GB2266241B
(en )
1996-02-28
Treatment of pastures
GB9324852D0
(en )
1994-01-19
A medicament for the treatment of metasteses
AU5397994A
(en )
1994-08-18
Treatment of skin disorders
EG19885A
(en )
1996-03-31
Medicament for the treatment of hyperlipidaemia and/or atherosolerosis